The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to ...

Deerfield Management accused Alcon of obstructing Aurion’s IPO plans so it could acquire the startup “at a discount.” ...

In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the evolution of women's inclusion in ...

Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year ...

Looking for a biopharma job in Indiana? Check out the BioSpace list of seven companies hiring life sciences professionals ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

The announcement by the Department of Health and Human Services highlighted a flurry of moves, which also include the shifting of departments. Also this week, HHS Secretary Robert F. Kennedy Jr.

Makary earlier this month distanced himself from the recent shake-ups at the FDA, including the cancellation of its vaccines ...

There are glimmers of hope, however, with Eisai reporting last month that it is on track to meet that fiscal 2024 sales ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...